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The Drosha-DGCR8 complex, also known as Micro-
processor, is essential for microRNA (miRNA) matu-
ration. Drosha functions as the catalytic subunit,
while DGCR8 (also known as Pasha) recognizes the
RNA substrate. Although the action mechanism of
this complex has been intensively studied, it remains
unclear how Drosha and DGCR8 are regulated and if
these proteins have any additional role(s) apart from
miRNA processing. Here, we report that Drosha and
DGCR8 regulate each other posttranscriptionally.
The Drosha-DGCR8 complex cleaves the hairpin
structures embedded in the DGCR8 mRNA and
thereby destabilizes the mRNA. We further find that
DGCR8 stabilizes the Drosha protein via protein-
protein interaction. This crossregulation between
Drosha and DGCR8 may contribute to the homeo-
static control of miRNA biogenesis. Furthermore,
microarray analyses suggest that a number ofmRNAs
may be downregulated in a Microprocessor-depen-
dent, miRNA-independent manner. Our study reveals
a previously unsuspected function of Microprocessor
in mRNA stability control.
INTRODUCTION
MicroRNAs (miRNAs) are 22 nt small noncoding RNAs that
control gene expression at the posttranscriptional level through
translational inhibition and destabilization of their target mRNAs
(Ambros et al., 2003; Filipowicz et al., 2008). MiRNAs were
initially discovered from C. elegans, as regulatory molecules
modulating the developmental timing (Lee et al., 1993).
Hundreds of miRNAs have been discovered in most eukaryotic
species, and their diverse roles are rapidly being elucidated
(Bushati and Cohen, 2007; Jones-Rhoades et al., 2006). Links
betweenmiRNA and human diseases such as cancer and neuro-
degenerative diseases have also been established (Bushati and
Cohen, 2007; Hebert et al., 2008; Wang et al., 2008a).MiRNAs originate from long primary transcripts called pri-
miRNAs (Lee et al., 2002). The hairpin embedded in pri-miRNA
is processed in the nucleus byDrosha, amember of ribonuclease
III family (RNase III), and converted into precursor miRNA (pre-
miRNA) (Lee et al., 2003). This processing is crucial for the vast
majority of miRNAs, although a small subgroup of miRNAs found
in short introns can bypass this step (Okamura et al., 2007; Ruby
et al., 2007). The pre-miRNA is then exported to the cytoplasmby
exportin-5 and turned into 22 nt miRNA duplex by Dicer,
another RNase III protein (Liu et al., 2008). One strand of the
miRNA duplex is incorporated into an effector complex known
as RNA-induced silencing complex (RISC) (Liu et al., 2008).
Drosha has two RNase III domains and one double-stranded
RNAbinding domain (dsRBD). The twoRNase III domains (RIIIDa
and RIIIDb) form an intramolecular dimer and cleave the 30 and 50
strands of the stem, respectively (Han et al., 2004). Because the
dsRBD of Drosha is insufficient for substrate binding, Drosha
needs a partner protein surrogating the RNA recognition func-
tion. DGCR8 (also known as Pasha) is the cofactor that interacts
with Drosha and forms a functional complex called the ‘‘Micro-
processor’’ (Denli et al., 2004; Gregory et al., 2004; Han et al.,
2004; Landthaler et al., 2004). DGCR8 contains two dsRBDs
and recognizes the unique features of the pri-miRNA, which
include the ssRNA segments flanking a stem of appropriate
length (Han et al., 2006). DGCR8 anchors at the ssRNA-dsRNA
junction and directs Drosha to cleave 11 bp away from the
junction (Han et al., 2006).
Although the mechanism of Microprocessor activity has been
intensively interrogated, it remains largely unknown how its
components are regulated. In a comparative genomics study,
Pedersen et al. predicted a couple of conserved hairpins in
DGCR8 mRNA, whose folds are similar to pri-miRNA structure,
which implied that the hairpins may be involved in the autoregu-
lation of DGCR8 (Pedersen et al., 2006). A possible link between
DGCR8 and heme-mediated signal transduction pathway was
also proposed on the basis of the finding that DGCR8 is
a heme-binding protein (Faller et al., 2007).
When Microprocessor activity is dysregulated, the miRNA
pool is altered, disrupting the normal cellular function. For
instance, Dgcr8 knockout mouse embryonic stem (ES) cells do
not produce miRNAs with resulting defects in proliferation orCell 136, 75–84, January 9, 2009 ª2009 Elsevier Inc. 75
differentiation (Wang et al., 2007). Interestingly, in various human
cancers, miRNA expression was found to be generally sup-
pressed (Lu et al., 2005), implicating that precise control of
miRNA biogenesis may be critical in guarding the cells against
malignancy. It was proposed that Drosha processing of certain
miRNAs is suppressed in tumor cells and undifferentiated cells
(Thomson et al., 2006), although the mechanism of the suppres-
sion remains unclear.
In the present study, we show that DGCR8 is negatively regu-
lated by the Drosha-DGCR8 complex through mRNA cleavage.
We further report that DGCR8 positively regulates Drosha by
protein stabilization. These auto- and crossregulations between
Drosha and DGCR8 may help maintain the homeostatic control
of miRNA biogenesis.
RESULTS
Drosha Suppresses the Expression of DGCR8
To study the function of Drosha in pri-miRNA processing, we
routinely use RNAi technique to deplete Drosha in HeLa cells
and analyze RNA by RT-PCR and northern blotting. While per-
forming these RNAi experiments, we observed that the DGCR8
mRNA level increased significantly in Drosha-depleted cells
(Figure 1A). Quantitative real time PCR (qRT-PCR) showed 3
fold increase in the DGCR8 mRNA level under this condition.
As with the mRNA level, the DGCR8 protein level also increased
3- to 4-fold after Drosha knockdown, as determined by western
blotting (Figure 1B). To exclude the possibility that this is caused
by off-target effects, we used a transdominant negative Drosha
mutant (TN Drosha) containing point mutations in both RNase III
domains. When this mutant protein was overexpressed, Drosha
processing of pri-miRNA was effectively blocked (Figure 1C and
Figure S1A available online). The DGCR8 mRNA level increased
under this condition (Figure 1C, lane 3), whereas it decreased
when wild-type Drosha was overexpressed (Figure 1C, lane 2).
In accordance with themRNA level, endogenous DGCR8 protein
accumulated after TN Drosha overexpression (Figure 1C, lane 6,
and Figure S1A). A similar experiment was carried out with
a transdominant negative DGCR8 mutant (Figure S1B). The
mutant called mDRBD1&2 DGCR8 (m1&2) contains point muta-
tions in both dsRBDs (Yeom et al., 2006). Expression of this
DGCR8 mutant upregulated the endogenous DGCR8 mRNA
(Figure S1B, lane 4), suggesting that it is the reduction of the
wild-type Drosha-DGCR8 activity that is responsible for the
accumulation of DGCR8 mRNA.
Drosha Regulates the DGCR8 mRNA
Posttranscriptionally in the Nucleus
To unravel the mechanism of this regulation, we first determined
the RNA polymerase density on DGCR8 gene by nuclear runoff
assay. For this experiment, a HeLa cell line that expresses pri-
miR-30a from the tetracycline-inducible promoter was used.
The inducible pri-miR-30a genewas used as a control for a differ-
entially transcribed gene. Polymerase density on DGCR8 did not
change after Drosha knockdown (Figure 1D), despite the
increase of the steady-state level of the DGCR8 mRNA (Fig-
ure S2A), which indicated that the regulation of DGCR8 may
occur posttranscriptionally.76 Cell 136, 75–84, January 9, 2009 ª2009 Elsevier Inc.To be certain of this result, we performed qRT-PCR to amplify
the intronic region of the DGCR8 pre-mRNA using a primer set
that bind to the first intron (Figure 1A). Knockdown of Drosha
had no effect on theDGCR8pre-mRNA level (DGCR8 first intron),
whereas it dramatically increased the mature DGCR8 mRNA
level (DGCR8 CDS). This was also confirmed by RT-PCR with
a different primer set that amplifies the first intron (Int1-Int1)
(Figure S2B). Thus, the DGCR8 mRNA is likely to be regulated
by Drosha after transcription and splicing of the first intron.
To examine whether Drosha affects the stability of the DGCR8
mRNA, we measured the turnover rate of the mRNA after block-
ing transcription by treating the cells with actinomycin D (ActD)
(Figure 1E and Figure S3). HEK293T cells were first transfected
with siRNA and then treated with ActD 40 hr later. Total RNA
was subsequently prepared on several time points and analyzed
by northern blotting. The DGCR8 mRNA prepared from Drosha-
depleted cells was more stable than that from control cells
(Figure 1E and Figure S3A). The RT-PCR analysis with RNAs
prepared from similarly treated cells confirmed that the half-life
of DGCR8 mRNA was lengthened upon Drosha depletion
(Figure S3B). Pri-miR-21 and GAPDH transcripts served as the
positive and negative controls, respectively.
Because the DGCR8 30 untranslated region (UTR) is predicted
to possess several miRNA target sites, it is conceivable that
mRNA destabilization is caused by RISC-associated miRNAs.
To test this possibility, we depletedDicer,which is another essen-
tial factor for miRNA biogenesis. The reduction of Dicer did not
increase the protein level of DGCR8 under this condition,
excluding the possibility that the observed suppression of
DGCR8 is mediated by RISC-associated miRNA (Figure 1B).
Accordingly, the mRNA level of DGCR8 did not increase in
Dicer-depletedcells, asdeterminedbyRT-PCR (Figure1F). Effec-
tive depletion of Dicer was confirmed by strong induction of
the p27 protein that is a known target of miR-221/222 (Figure 1B)
(Visone et al., 2007; Galardi et al., 2007; le Sage et al., 2007).
Furthermore, when the cells were separated into nuclear and
cytoplasmic fractions after Drosha depletion, the accumulation
of the DGCR8 mRNA was observed in both fractions (Figure 1F,
lanes 7 and 11). The overexpression of transdominant negative
mutant (TN Drosha) also induced the DGCR8 mRNA accumula-
tion in the nucleus, as well as in the cytoplasm (Figure S4). The
siRNA against DGCR8 (siDGCR8) reduced DGCR8 mRNA in
the cytoplasm (Figure 1F, lane 12), as expected since siRNAs
silence their target mRNAs mainly in the cytoplasm (Zeng and
Cullen, 2002). The same siRNA increased DGCR8 mRNA in the
nucleus (Figure 1F, lane 8), indicating that DGCR8 protein may
be involved in the nuclear destruction of its ownmRNA. Because
Microprocessor acts in the nucleus, these results indicate that
Microprocessor may directly target the DGCR8 mRNA.
Hairpin Structures in the DGCR8 mRNA
Are Cleaved by Drosha In Vitro
Pedersen et al. reported that vertebrate DGCR8 mRNAs contain
two conserved hairpins in the 50 UTR (hairpin A) and in the coding
sequence near the start codon (hairpin B) (Figure 2A) (Pedersen
et al., 2006). These structures were detected by an algorithm
called EvoFold, which searches for evolutionarily conserved
secondary structures (Pedersen et al., 2006). Because these
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Figure 1. Drosha Downregulates DGCR8 mRNA and Protein Expression at the Posttranscriptional Level
(A) Quantitative real-time PCR (qRT-PCR) after Drosha depletion. Total RNA was prepared from HeLa cells 72 hr after transfection of siRNA against Drosha
(siDrosha). siRNA against GFP (siGFP) was used as a control. Three biologically independent experiments were performed for quantification (mean ±SD).
(B) Western blot analysis after knockdown. HeLa cell extract was prepared 72 hr after siRNA transfection. The p27, a target of miR-221/222, is used as a control.
Quantitative results are shown in the right panel. Three independent experiments were performed for quantification (mean ±SD).
(C) RT-PCR and western blot analysis after overexpression of the transdominant negative (TN) Drosha mutant in HEK293T cells. Drosha (TN) is a mutant lacking
the catalytic activity. Wild-type (WT) Drosha was used as a control. Though the juxtaposed lanes are not contiguous, all of them are from a single gel, which is true
for all the membranes with dashed lines. The primer set, Ex1-Ex2, amplifies endogenous DGCR8 mRNA.
(D) Nuclear runoff assay after Drosha depletion. The nuclei of miR-30a-inducible HeLa cells were prepared after siRNA transfection and doxycycline treatment.
For quantification of the nuclear runoff, the band intensity was determined by phosphoimager and normalized against b-actin levels. Two independent experi-
ments were performed for quantification (mean ±SD).
(E) Turnover rate ofDGCR8mRNA inDrosha-depleted cells. ActinomycinD (ActD) (5mg/ml) was added toHEK293T cells 40hr after siRNA transfection. Total RNAs
areprepared at the indicated point after ActD treatment. The band intensity fromnorthern blotwasmeasured byMulti Gaugeprogram (Fuji) and normalized against
GAPDHmRNA. The relativeDGCR8mRNA levelswere determined from three independent experiments (mean±SD). A representative data is shown inFigure S3A.
(F) RT-PCR analysis of DGCR8 mRNA in subcellular fractions after RNAi in HEK293T cells. The exon and intron of GAPDH were amplified as markers of
cytoplasmic RNA and nuclear RNA, respectively.hairpins have similar features to those of pri-miRNAs (Han et al.,
2006), we investigated whether the hairpins can be cleaved by
Drosha through in vitro processing assay (Lee et al., 2003). The
transcript used for this assay contains the 50 UTR (+69–+350
nt) and the first 217 nt of the coding region (+351–+567 nt)
(Figure 2A). When this RNA was incubated with cell extract or
immunoprecipitated protein complex, two fragments were
generated, demonstrating that the hairpins can be cleaved by
Drosha (Figure 2B). The lengths of these products (60 nt and
76 nt) were similar to those of typical pre-miRNAs. In order to
validate that these fragments were produced by Drosha not bycontaminating nucleases, we performed a processing assay
using a Drosha mutant, E110aQ (Figure 2C). The E110aQ
contains a point mutation (E to Q) at the catalytic site of RIIIDa
(Han et al., 2004). Because this mutant can cleave only the 50
strand of a hairpin, it released larger cleavage fragments as
expected (Figure 2C). Pri-miR-16-1 was used as a control. On
the basis of these results, we conclude that the hairpin structures
in the DGCR8 mRNA are cleaved by Microprocessor. It is noted
that the DGCR8 hairpins are cleaved less efficiently than pri-miR-
16-1, which is expected if the DGCR8 hairpins have evolved
to modulate, rather than to abrogate, DGCR8 expression.Cell 136, 75–84, January 9, 2009 ª2009 Elsevier Inc. 77
Consistent with this idea, pri-miRNAs such as pri-miR-16-1,
pri-let-7a-1, and pri-miR-21 were induced more strongly (4- to
10-fold) than DGCR8 mRNA (3- to 4-fold) in Drosha-depleted
cells (Figures 1A and 1F).
To clarify the identity of the fragments, we determined the
cleavage sites by a directional cloning method (Elbashir et al.,
2001). The RNAs were gel purified, ligated with adapters, and
reverse transcribed. The cDNAs were then amplified by PCR,
cloned, and sequenced. We found that the longer cleavage frag-
ment (indicatedwith a red triangle)wascreated from thecleavage
at the site A1 of hairpin A,whereas the smaller fragments (marked
with a blue triangle) were derived from two different cleavage
sites—at the site A2 of hairpin A and the site B1 of hairpin
B (Figure 2D). The mapping of the cleavage sites indicated that
the fragments have short 30 overhangs (Figure 2D), which were
expected for the products of RNase III-mediated cleavage.
The cleavage sites were 6–14 nt away from the ssRNA-dsRNA
junction,dependingontheconditions thatwereused forsecondary
A
B
D
C
Figure 2. The Hairpins in DGCR8 mRNA Are
Cleaved by Drosha In Vitro
(A) Partial sequences of DGCR8 mRNA of human,
mouse, rat, chicken, and zebrafish. There are two
hairpin structures, hairpin A in the 50 UTR and
hairpin B in the coding region. A black bar presents
a template for in vitro transcription. This figure is
adapted from Pedersen et al. (2006).
(B) In vitro processing of the DGCR8 hairpins.
Internally labeled hairpins were incubated with
total cell extract (TCE) or FLAG-immunopurified
(FLAG-IP) Drosha. Cleavage fragments are
marked by red or blue triangles.
(C) In vitro processing of the DGCR8 hairpins with
a Drosha mutant E110aQ. Pri-miR-16-1 was used
as a control.
(D) Cleavage site mapping of the two hairpins. The
cleavage sites are indicated with triangles. The
color of the triangles shows the origin of the frag-
ments presented in Figure 2B. Size of the triangle
reflects the clone frequency such that the frequen-
cies of 99%–75%, 74%–50%, and 49%–25% are
shown with large, medium, and small triangles,
respectively. Thecleavagesiteswithclone frequen-
cies of under 25% are not presented in this figure.
Gray lines under the hairpins represent the binding
sites for the probes used for northern blotting.
structure prediction. This is consistent with
the previous results on Drosha cleavage
site selection (Han et al., 2006).
Drosha-Mediated Destabilization
of the DGCR8 mRNA Is Conserved
in Other Species
The DGCR8 mRNA is highly conserved
among vertebrates, including mouse, rat,
chicken, and zebrafish (Pedersen et al.,
2006) (Figure 2A), so we asked whether
the regulatory mechanism of DGCR8 is
evolutionary conserved. For this, siRNA
targeting mouse Drosha was transfected into NIH 3T3 cells
(Figure 3A and Figure S5A) and mouse embryonic stem (mES)
cells (Figure S6). As in humans, mouse DGCR8 mRNA and
protein accumulated when Drosha was knocked down, indi-
cating evolutionary conservation of the regulation.
We also found, using EvoFold, that the 50 UTR of Drosophila
DGCR8/Pasha mRNA contains a hairpin structure, although the
sequences themselves are not conserved with vertebrates
(Figure S5C). When we knocked-down Drosophila Drosha in S2
cells, Pasha mRNA accumulated (Figure 3B and Figure S5B).
This suggests that a similar regulatory mechanism may be
present in invertebrates and thus that this regulation may have
played a fundamental role throughout animal evolution.
Drosha Cleaves the DGCR8 mRNA In Vivo
To confirm that the Drosha-mediated cleavage event of the
DGCR8 mRNA occurs in vivo, we carried out a northern blot
assay to detect the cleavage products in the cell. When we78 Cell 136, 75–84, January 9, 2009 ª2009 Elsevier Inc.
used probes that are complementary to hairpin A, we could
detect an 60 nt fragment (Figure 4A). The level of this RNA
was reduced by knockdown of Drosha or DGCR8 (Figure 4A,
lanes 3 and 4), which is expected for the product of Micropro-
cessor. An 60 nt RNA was also produced from the plasmid
that ectopically expresses the RNA containing both hairpins
(Figure 4B, lane 2). This indicated that the 60 nt band corre-
sponds to the cleavage product generated from hairpin A.
When we used probes that are complementary to the stem
sequence of hairpin B, we could not detect any band by northern
blotting (Figures S6A and S7). This suggested that Drosha may
prefer the cleavage site A2 of hairpin A to the other sites for
cleavage in vivo (Figure 2D). It is also plausible that the other
fragments (the 76 nt fragment from the site A1 and the 60 nt
fragment from the site B1) may be degraded rapidly in the cell,
defying detection by northern blotting.
Notably, we could not detect any small RNA of 22 nt, even
when small RNA was enriched (Figure 4 and Figure S6A). More-
over, we observed that when we carried out subcellular fraction-
ation, the 60 nt fragment was confined in the nuclear fraction
(Figure 4C). This may be because the nuclear export of
this 60 nt fragment is very inefficient or because the fragment
A B
Figure 3. Conservation of the Regulation of DGCR8
(A) RT-PCR and western blot analysis after mouse Drosha and mouse DGCR8
depletion. Total RNA and cell extract of NIH 3T3 cells were prepared 72 hr after
siRNA transfection.
(B) RT-PCR analysis after Drosha knockdown in D. melanogaster S2 cells.
Total RNA of S2 cells was prepared 7 days after addition of long double-
stranded RNAs that target fly Drosha (dsDrosha). Reverse transcription was
carried out with random primer. Pri-Bantam was amplified as a positive
control.gets degraded rapidly in the cytoplasm. Thus, these results
suggest that the DGCR8 hairpin may not producemature miRNA
and that the hairpin may function as an RNA instability element
rather than as a precursor for miRNA biogenesis.
To ask whether the hairpins are required for Drosha-depen-
dent regulation, we generated luciferase reporter constructs,
one containing the DGCR8 hairpins and the other with the hair-
pins deleted (Figure S8). The reporter construct possessing the
hairpin region is induced by Drosha or DGCR8 knockdown,
whereas the reporter lacking the hairpins is not responsive to
the knockdown. This indicates that the hairpins are necessary
for Microprocessor-dependent gene regulation.
DGCR8 Protein Stabilizes the Drosha Protein
When we depleted DGCR8 by RNAi, we also noticed that there
may be an additional layer of regulation between Drosha and
DGCR8. Namely, the protein level of the endogenous Drosha
was downregulated after DGCR8 knockdown (Figure 1B). This
reduction at the Drosha protein level was not accompanied by
that of the Drosha mRNA level (Figure 1F and Figure S2B).
To further examine the effect of DGCR8 on Drosha, we ectop-
ically expressed FLAG-tagged DGCR8 and Drosha proteins in
HEK293T cells. Drosha protein accumulated significantly when
coexpressed with DGCR8 protein (Figure 5A). In addition, the
endogenous Drosha protein increased when DGCR8 was over-
expressed (Figure 5B). To confirm and extend this initial finding,
we examined DGCR8 deletion mutants that cannot bind to
Drosha. We formerly showed that the mutants DGCR8[1-483]
and DGCR8[1-614] do not interact with Drosha, whereas the
mutantsDGCR8[276-773] andDGCR8[m1&2] canbind toDrosha
(Yeom et al., 2006). When coexpressed with Drosha, the DGCR8
mutants that cannot bind to Drosha failed to upregulate Drosha
(Figure 5C, lanes 4 and 5). It is noted that we made a related
observation with different DGCR8 mutants (Yeom et al., 2006).
Taken together, these results indicate that DGCR8 may stabilize
Drosha through direct protein-protein interaction.
To further test this hypothesis, we examined Dgcr8 knockout
(KO) mouse ES cells (Wang et al., 2007). We compared the
protein expression levels in wild-type homozygote (flox/flox),A B C Figure 4. Drosha Cleaves the DGCR8mRNA
In Vivo
(A) Northern blot assay to detect the cleavage frag-
ments from the hairpin A in HEK293T cells. Probe
is complementary to the 50 stem region of hairpin
A marked as a gray underline in Figure 2D. Small
RNAs under 200 nt were enriched after siRNA
transfection. As a loading control, tRNA was
probed. Protein knockdown was confirmed by
western blotting.
(B) Northern blot assay. Total RNAs were prepared
from HEK293T cells transfected with either empty
vector or the plasmid expressing both hairpins.
(C) Northern blot assay. HEK293T cells were frac-
tionated into nucleus and cytoplasm. The RNAs
were extracted from each fraction, dissolved in
the same amount of TE, and loaded on the gel.
Fractionation efficiency is confirmed by measure-
ment of GAPDH mRNA and pri-miR-21 as the
cytoplasmic and nuclear markers, respectively.Cell 136, 75–84, January 9, 2009 ª2009 Elsevier Inc. 79
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Figure 5. Drosha Is Positively Controlled byDGCR8 through Protein-
Protein Interaction
(A) Western blot analysis of the transiently expressed Drosha protein. In
HEK293T cells, Drosha-FLAG was transiently transfected with FLAG null
vector or DGCR8-FLAG.
(B) Western blot analysis of endogenous Drosha protein after overexpression
of DGCR8. V5-tagged DGCR8 was transiently expressed in HeLa cells.
(C)Western blot analysis after transient expression of various DGCR8mutants.
The Drosha-FLAG and V5-DGCR8 mutants were coexpressed in HEK293T
cells. Though the juxtaposed lanes are not contiguous, all of them are from
a single gel, which is true for all the membranes with dashed lines. DGCR8
mutants were schematized and their Drosha binding abilities are presented
on the right.
A B
C Dheterozygote (D/flox), and KO homozygote (D/D) lines by
western blot assay. In Dgcr8 null ES cells, the Drosha protein
levels were significantly lower than that in wild-type cells,
whereas they remained unchanged in Dicer KO ES cells
(Figure 6A). The Drosha mRNA levels were comparable between
wild-type and Dgcr8 null ES cells (Figure 6B). We also examined
mouse embryonic fibroblast (MEF) from Dgcr8 KO mouse
(Figure S9). Like in ES cells, the Drosha protein was expressed
at a lower level (40%) in the Dgcr8 D/D MEF compared to the
wild-type cells (Figure S9A), even though the mRNA level of Dro-
sha in D/D MEF remained similar to that in wild-type or D/flox
MEF (Figure S9B). This result indicates that in the absence of
DGCR8, Drosha is downregulated and that DGCR8 may be
required to maintain the normal level of Drosha protein.
Interestingly, we noticed that neither DGCR8 nor Drosha
protein levels appeared to be significantly diminished in hetero-
zygote ES or MEF (Figure 6C, lane 2, and Figure S9C, lane 2),
although it is expected that only 50% of DGCR8 is expressed in
these cells compared to thewild-type cells. To test whether there
is compensatory expression from the remaining Dgcr8 allele in
the heterozygous background, we performed qRT-PCR for
exon 3 of DGCR8, which only measures expression from the
wild-type allele (Figure 6D). The DGCR8 mRNA level in heterozy-
gous cells is also 90% compared to that of the wild-type
(Figure 6D). Consistent with the DGCR8 level, the miR-130a level
in heterozygous cells is also similar to that of wild-type cells
(Figure S9D). This suggests that the reduction of DGCR8 in
heterozygous cells resulted in the decrease of Microprocessor80 Cell 136, 75–84, January 9, 2009 ª2009 Elsevier Inc.activity, which in turn enhanced the expression of DGCR8protein
through the feedback circuit. Thus, the feedback involving Dro-
sha and DGCR8 may play a significant role in vivo in the control
of Microprocessor activity and miRNA production.
DISCUSSION
Here, we report two main findings (Figure 7). First, Drosha can
act directly to eliminate a specific mRNA. Thus, Drosha plays
an additional role in posttranscriptional control apart from
miRNA processing. Second, this direct action of Drosha is part
of a feedback control system between Drosha and DGCR8,
which also includes a protein stabilization component.
Figure 6. Expression of Drosha and DGCR8 in Dgcr8 KO Mouse ES
Cells
(A) Western blot analysis of Drosha in mouse ES cells. D/flox indicates hetero-
zygote cells, and D/D indicates homozygous null cells. Two different KO lines
(c1 and c2) were used for the experiments (lanes 3 and 4). TheDicer KO ES line
(dicer D/D) was used as a control (Babiarz et al., 2008).
(B) Quantitation of the Drosha mRNA by Affymetrix chip analysis. Three
independent experiments were performed (mean ±SD). The methods are
described in Wang et al. (2008b).
(C) Western blot analysis of DGCR8 in mouse ES cells. The asterisk represents
a nonspecific band which serves as a loading control.
(D) Quantitative real time PCR (qRT-PCR) of the DGCR8 mRNA in Dgcr8 KO
mES cell. The relative DGCR8 mRNA levels were determined in wild-type
(flox/flox) and heterozygote (D/flox). Three independent experiments were
performed for quantification (mean ±SD).
Regulation of Microprocessor Activity
Most eukaryotic RNase III proteins interact with dsRBD-contain-
ing proteins. It seems to be a general theme that RNase III
proteins are stabilized by their binding partners. For instance,
human Dicer binds to PACT, a protein containing three dsRBDs
(Lee et al., 2006). Depletion of PACT results in the reduction of
Dicer protein. Similarly, in Drosophila, Dicer-2, and a dsRNA-
binding protein, R2D2, interact with each other and depend on
each other for stable expression (Liu et al., 2003). In the present
study, we show that DGCR8 stabilizes Drosha protein through
protein-protein interaction (Figure 5). Although the molecular
details of such protein degradation/stabilization remain to be
determined, the data from mouse KO cells suggest that protein
stability control of RNase III may be significant in vivo.
Drosha and its cofactor, DGCR8, are engaged in a complex
regulatory circuit (Figure 7). If Drosha and DGCR8 levels are
elevated in the cell, Microprocessor would cleave and destabi-
lize the DGCR8 mRNA, resulting in the reduction of DGCR8.
This will in turn reduces the Drosha protein through protein
destabilization, lowering the Microprocessor activity. This autor-
egulatory feedback circuit may help minimize the potentially
harmful fluctuation of Microprocessor activity in the cells. In light
of this, it is noteworthy that we observe an interesting dosage
compensation effect in Dgcr8 heterozygous cells that contains
only one copy of the Dgcr8 gene. In heterozygous cells, the
DGCR8 level is expected to be 50% of that in wild-type cells.
However, the DGCR8 protein level in heterozygous cells is
over 80% of the normal level (Figure 6 and Figure S9). Moreover,
the miR-130a level in heterozygous cells is similar to that in wild-
type MEF cells (Figure S9). Similarly, the Blelloch group previ-
ously showed that miRNA levels in Dgcr8 heterozygous ES cells
are over 85% of those in wild-type ES cells (Wang et al., 2007).
Thus, Microprocessor activity in heterozygous cells may be
maintained at over 80% of that in wild-type cells. It was recently
reported that Dgcr8 heterozygous mice produce less miRNAs in
the brain than does the wild-type (Stark et al., 2008). However,
significant changes were observed only for a small subset of
miRNAs, while the majority of miRNAs remained largely unaf-
Figure 7. Model for the Crossregulation
between Drosha and DGCR8
The Drosha protein cleaves the hairpins on the
DGCR8 mRNA and destabilizes the mRNA, while
the DGCR8 protein positively regulates the Drosha
protein via protein-protein interaction. Drosha may
be involved in the stability control of other mRNAs.
fected. Taken together, these results
indicate that the feedback circuit found
in our study may be significant in vivo
and contribute to tight control of miRNA
production in the cell. The evolutionary
evidence also suggests that the regula-
tions between Drosha and DGCR8
may play an important role in controlling
miRNA biogenesis in vivo. The hairpins in
DGCR8mRNAsareconserved throughout
evolution, and similar regulation occurs
not only in mammalian cells but also in insect cells (Figure 3).
Further work will be required to confirm the physiological signifi-
cance of this regulation.
Both Drosha and DGCR8 are ubiquitously expressed proteins,
but the levels of these proteins vary depending on the cell types
(J.H. and V.N.K., unpublished data). It is conceivable that Drosha
and DGCR8 are modulated by additional factors in a cell type-
specific manner. Previous studies showed that Drosha and
DGCR8 are associated with multiple factors (Gregory et al.,
2004; Faller et al., 2007; Shiohama et al., 2007). The functional
significance of these interactions remains to be determined.
Given the general suppression of miRNAs in cancer and stem
cells (Lu et al., 2005; Thomson et al., 2006), it would be particu-
larly interesting to investigate how the miRNA processing activ-
ities are modulated during tumorigenesis and cell differentiation.
A Function for Drosha as a Regulator of mRNA Stability
RNase III family members vary widely and play diverse roles in
RNA metabolism (MacRae and Doudna, 2007). For instance,
yeast RNase III protein, Rnt1, functions in the processing of
pre-rRNAs, small nuclear RNAs, and small nucleolar RNAs.
Rnt1 also cleaves and controls certain specific mRNAs. Dicer
functions mainly in small RNA pathways, but it was recently
shown that human Dicer can target mRNAs with CNG repeat-
containing hairpins (Krol et al., 2007). Drosha is known to play
a critical role in miRNA maturation (Lee et al., 2003). Our present
study reveals a function of Drosha in mRNA stability control.
The EvoFold program predicted that vertebrate DGCR8
mRNAs contain two highly conserved hairpin structures, both
of which can be cleaved by Drosha in vitro (Figure 2). We de-
tected the cleavage product from the first hairpin by northern
blotting (Figure 4). In recent deep sequencing studies, small
RNAs from the second hairpin of DGCR8 mRNA were detected
and named miR-1306 (Friedlander et al., 2008; Morin et al.,
2008). From the peripheral blood of a dog, miR-1306-5p was
sequenced (Friedlander et al., 2008), while miR-1306-3p was
identified in human embryonic stem cells (Morin et al., 2008).
Taken together, both hairpins (A and B) are cleaved byCell 136, 75–84, January 9, 2009 ª2009 Elsevier Inc. 81
Microprocessor in at least certain cell types. But these hairpins
seem to be quite inefficient precursors for miRNA biogenesis
because the small RNAs were detected only by massive parallel
sequencing approach (Friedlander et al., 2008; Morin et al.,
2008).So it remains tobedeterminedwhethermiR-1306 isa func-
tionalmiRNA, aby-product of regulatedmRNAcleavage, or both.
It is noteworthy that over 10% of the known miRNAs are
located in the exonic regions of protein-coding or noncoding
transcripts (Kim and Kim, 2007; Morin et al., 2008; Rodriguez
et al., 2004). Because Drosha processing is expected to desta-
bilize the host transcripts, it would be interesting to investigate
whether such exonic miRNA hairpins serve dual roles as RNA
instability elements as well as miRNA precursors. It would also
be of great interest to search for additional mRNAs that are
controlled by Drosha. To begin investigating this possibility, we
performed a series of knockdown and microarray experiments.
We found that 335 out of 16,309 mRNAs detected in HeLa cells
by Affymetrix chip are upregulated over 2-fold in Drosha-
depleted cells without significant changes in Dicer-depleted
cells (Figure S10A, a; Group I; shown in red). Most mRNAs that
are upregulated in Drosha-depleted cells are also upregulated
in DGCR8-depleted cells (Figure S10A, b, and Figure S10B, a;
Group II; shown in dark blue). Out of the 335mRNAs, 104mRNAs
are elevated over 2-fold in DGCR8-depleted cells without
changing significantly in Ago2-depleted cells (Figure S10A, b;
Group II; shown in dark blue). These genes do not show signifi-
cant fold changes in Ago2 knockdown cells (Figure S10B, b).
Thus, in HeLa cells, 100 genes are Microprocessor dependent
and RISC independent. Although it is possible that some of these
genes are regulated indirectly through unknown mechanism(s),
our result implies that theremay be a significant number of genes
that are directly controlled by Microprocessor.
EXPERIMENTAL PROCEDURES
RNA Interference
Thirty two nanomolar of siRNA duplex were transfected into HeLa, HEK293T,
or NIH 3T3 cells with Lipofectamine2000 transfection reagent (Invitrogen)
according to the manufacturer’s instructions. siRNAs were purchased from
Samchully Pharmaceuticals. Target sequences of siDrosha, siDGCR8, and
siDicer are 50-AACGAGUAGGCUUCGUGACUU-30, 50-AACAUCGGACAAGA
GUGUGAU-30, and50-UGCUUGAAGCAGCUCUGGA-30, respectively. A target
sequence of mouse siDrosha, siDGCR8, and siDicer are 50-AGAUCACCGU
CUCUAGAAA-30, 50- AACAAUUUGGAGCUAGAUGAA-30 and 50-ACACAGCA
GUUGUCCUAAA-30.
Fifteen micrograms of long dsRNAs targeted on Dm Drosha was added
directly to the media of S2 cells grown in 6 well plates. Cells were treated with
dsRNA three times in total on days 0, 2, and 4. The cells were then harvested
on day 7.
Long Double-Stranded RNA Production for Fly Gene Knockdown
To generate long double-stranded RNAs, each strand of target mRNA is tran-
scribed by MEGASCRIPT T7 transcription kit (Ambion). Then single-stranded
RNAswere annealed by incubation at 65C for 30min followed by slow cooling
to room temperature. DNA templates for transcription are 700 bp in length,
and they were amplified by PCR. All PCR primers contain T7 RNA polymerase
binding site 50-GAATTAATACGACTCACTATAGGGAGA-30. Primer sequences
after T7 polymerase binding site are the following: Dm Drosha, 50-GGTGTTC
CCTCTCACAACTATTCTTC-30 (forward) and 50-GGGCGTTCATCTTCTTCA
CATAGTC-30 (reverse); and Luciferase, 50- TTGTCAGACACATTTCCGAAA
A-30 (forward) and 50-TCTAGCTAAGCCGGATCAGCTG-30 (reverse).82 Cell 136, 75–84, January 9, 2009 ª2009 Elsevier Inc.RNA Extraction
HeLa, HEK293T, NIH 3T3, and mES cells were lysed directly in tissue culture
plates with Trizol (Invitrogen) reagent. RNA was prepared according to the
manufacturer’s protocol. Total RNA of S2 cells and Dgcr8 knockout MEF cells
was prepared from cell pellets and frozen cell pellets, respectively, with Trizol
reagent.
RT-PCR
DNase I-treated total RNAs were used for the first-strand cDNA synthesis.
HeLa, HEK293T, NIH 3T3, and DGCR8 KO MEF cDNAs were synthesized
with M-MuLV reverse transcriptase (Fermentas) and Oligo-dT primers (Invitro-
gen) according to the manufacturer’s protocols. Reverse transcription of S2
total RNA was carried out with Superscript II (Invitrogen) and random primer
(Invitrogen). Dgcr8 knockout mES total RNA was reverse transcribed with
Superscript II (Invitrogen) and Oligo dT (Invitrogen). Reverse transcription of
fly RNA was carried out with Superscript II and random primer (Invitrogen).
Primer sequences are given in Figures S11 and S12.
Quantitative Real-Time PCR
The comparative Ct method with SYBR Green was conducted with the 7300
Real-Time PCR System (Applied Biosystems). Human b-actin mRNA was
measured as a control in HeLa cells. In Dgcr8 knockout mES cells, mouse
b-actin mRNA was used as an endogenous control (Wang et al., 2007),
whereas in A3-1 mES cells, mouse GAPDHmRNA was used for normalization.
Mouse DGCR8 primers were designed to bind to the exon 3 that is deleted in
KO cells. Primer sequences are given in Figures S11 and S13.
Western Blot Analysis
HeLa, HEK293T, or NIH 3T3 cells were collected at 72 hr after siRNA transfec-
tion. The cells were dispersed by pipetting in lysis buffer (10 mM Tris at pH 7.4,
1 mM ethylenediaminetetraacetic acid [EDTA] at pH 8.0, 500 mM NaCl, and
0.5% Triton X-100) and incubated for 30min on ice.Dgcr8 knockout mES cells
were collected at subconfluent density 48 hr after plating. Cell pellets were
rinsed with phosphate-buffered saline (PBS) then lysed in EBC buffer
(50 mM Tris at pH 8.0, 120 mM NaCl, 1% NP-40, and 13 Roche complete
inhibitor cocktail). Cells were dispersed by pipetting and incubated at 4C
for at least 45 min while rocking. Thirty to eighty micrograms of protein
samples were analyzed on 6%–10%SDS-polyacrylamide gels and transferred
to Hybond-C Extra membrane (Amersham) or Immuno-Blot PVDF membrane
(Biorad). Primary antibodies used in this study are rabbit anti-Drosha antibody
(Upstate Biotechnologies and abCamplc.), rabbit anti-DGCR8 antibody raised
against recombinant DGCR8 protein prepared in E. coli (Han et al., 2004),
rabbit anti-alpha Tubulin antibody (Abfrontier co., Ltd.), mouse anti-alpha
Tubulin (Sigma), goat anti-b-actin (Santa Cruz Biotechnology), mouse
anti-GAPDH antibody (Santa Cruz Biotechnology), and mouse anti-p27 anti-
body (BD Biosciences). For mouse Drosha detection, we use the antibody
from abCam.
Nuclear Runoff
Thirty two nanomolar of siGFP and siDrosha were transfected into HeLa cell
line that expresses pri-miR-30a from the tetracycline-inducible promoter.
Fourteen hours after transfection, cells were split into two dishes. Thirty hours
after cell splitting, 3 mg/ml of doxycycline was added to culture media. Nuclei
were harvested 39 hr after doxycycline treatment. Nuclear runoff assay was
carried out as previously (Kim et al., 2006) with full-length DNA fragment of
each gene.
Cloning and Sequencing of Cleavage Products Generated
from DGCR8 Hairpins
Hairpins of DGCR8 were transcribed in vitro and processed with immunopre-
cipitated Drosha-FLAG at 37C for 60 min. The60 nt and76 nt bands were
gel purified and ligated to the 30 adaptor. The ligated product was gel purified
and ligated to the 50 adaptor. The 30 and 50 adapters used for the cloning are
50-pUUUaaccgcgaattccagidT-30 and 50-acggaattcctcactAAA-30 (upper case,
RNA; lower case, DNA; p, phosphate; idT, inverted deoxythymidine), respec-
tively. For reverse transcription, a primer complementary to the 30 adaptor (3A-
reverse) was used. The sequence of 3A-reverse is 50-ACTGGAATTCGCGGT
TAAA-30. For determination of the 30 cleavage site of hairpin A, forward primer
(50-GATTTCCAATAATTGAGGCAGTG-30) and 3A-reverse primer were used
for PCR amplification. The PCR product was subcloned into pGEM-T-easy
(Promega). For mapping the 30 end of the 76 nt and 60 nt fragments,
20 and 13 clones were sequenced, respectively. For determination of the 50
cleavage site of hairpin A, forward primer which contains same sequence
with 50 adaptor (5A-forward) (50-ACGGAATTCCTCACTAAA-30) and reverse
primer (50-ATTGCTCTTTTCATTAATGTAG-30) were used for PCR amplifica-
tion. The PCR product was subcloned into pGEM-T-easy (Promega). For
mapping the 50end of the 76 nt and 60 nt fragments, 16 and 12 clones
were sequenced, respectively.
For determination of the 30 cleavage site of hairpin B, forward primer (50-
CAAACGTCCAGTGGTGCAGAG-30) and 3A-reverse primer were used for
PCR amplification. The PCR product was subcloned into pGEM-T-easy
(Promega), and 16 clones were sequenced. To determine the 50 cleavage
site of hairpin B, 5A-forward primer and reverse primer (50- CCACCAGAGC
CAACGTCCATTACC-30) were used for PCR amplification. The PCR product
was subcloned into pGEM-T-easy (Promega), and 11 clones were sequenced.
Plasmid Construction
So that the template for in vitro transcription of DGCR8 hairpins could be
produced, the partial 50 UTR and coding regions of human DGCR8were ampli-
fied from HeLa cDNA by PCR (forward primer, 50-CCTCAGGTAGAAGAAG
AAAGG-30, and reverse primer, 50-GAAGCTCCGTAGAAGTTGAAG-30). PCR
product was subcloned into pGEM-T easy vector (Promega) and sequenced.
For generation of a mammalian expression vector, the clone was inserted into
pcDNA3 vector.
Northern Blot Analysis of Small RNAs
Twenty five micrograms of HEK293T small RNA enriched bymirVana (Ambion)
and 50 mg of total HEK293TRNAwere resolved on 12.5%urea-polyacrylamide
gel. Nuclear and cytoplasmic RNA were loaded on 12.5% urea-polyacryl-
amide gel with the same volume ratio of prepared RNA after subcellular frac-
tionation of HEK293T cells grown in a 10 cm dish. Then RNAwas transferred to
a Zetaprobe-GT-membrane (Bio-Rad). Oligonucleotides complementary to
the 50 UTR of DGCR8 were end labeled with T4 polynucleotide kinase (Takara)
and used as probes. The sequence of probe in Figure 4 is 50-TGCCTCAATT
ATTGGAAATC-30.
Northern Blot Analysis of mRNAs
Total RNA was isolated from transfected HEK293T cells with TRIzol reagent
(Invitrogen), separated on denaturing formaldehyde agarose gels (15 mg per
well), and blotted onto Zeta-probe membranes (BioRad). 32P-labeled probes
were generated by the Prime-It Random Primer Labeling Kit (Stratagene)
with plasmid DNA fragments as the templates. After incubating the membrane
for 30 min at 68C in prehybridization solution (Express hybridization solution,
Clontech), hybridizations were carried out for 80 min at 68C. Membranes
were washed twice for 45 min at room temperature in washing solution I (23
sodium chloride-sodium citrate [SSC], 0.05% sodium dodecyl sulfate [SDS])
and then twice for 30 min at 50C in washing solution II (0.13 SSC, 1% SDS).
Subcellular Fractionation
HEK293T cells were grown in a 10 cm dish and they were collected in 450 ml of
ice-cold buffer A (10 mM HEPES at pH 7.9, 10 mM KCl, 1 mM dithiothreitol
[DTT], and 0.1 mM EDTA at pH 8.0). Cells were dispersed by pipetting and
incubated for 25 min on ice. Then 5 ml of 10% NP-40 was added, and cells
were incubated for 2 min on ice. The nuclei were precipitated by centrifugation
at 5000 rpm for 3 min in 4C. The supernatant was taken as the cytoplasmic
fraction.
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